Trials / Completed
CompletedNCT02622139
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 344 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Monocentric, prospective interventional study to assess the degree of disease activity with a multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's disease or ulcerative colitis.
Detailed description
The proposed study is designed as a pilot study to evaluate the usefulness of MSOT for the evaluation of disease activity in IBD patients. As current methods for the evaluation of intestinal inflammation in IBD have relevant restrictions, new, non-invasive, quantitative, and accurate modalities are urgently needed. In comparison to other techniques, MSOT provides relevant advantages such as non-invasive imaging, high spatial resolution (this is of special importance for the evaluation of the intestine, which can be only a few millimeters thick), and highly sensitive detection of specific molecules such as total hemoglobin or oxy- /deoxygenated hemoglobin. These advantages suggest MSOT as an outstanding technique for evaluating disease activity in IBD. The proposed study incorporates nearly no risk for participating patients and might provide relevant data for more a more in depth analysis of MSOT for IBD diagnosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multispectral Optoacoustic Tomography (MSOT) | MSOT for the evaluation of disease activity in IBD patients |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-10-01
- Completion
- 2019-12-01
- First posted
- 2015-12-04
- Last updated
- 2019-12-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02622139. Inclusion in this directory is not an endorsement.